Xiaoming Cui
Impact in
- Parasitology top 1%
- Vector-borne infectious diseases
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
- COVID-19 Clinical Research Studies
Papers in
- Pharmacology 20
- Pharmacogenetics and Drug Metabolism 19
- Inflammatory mediators and NSAID effects 2
- Parasitology 11
- Vector-borne infectious diseases 11
- Co-authors
- Ronald E. White (7 shared papers)Henry W. Strobel (7 shared papers)K.-C. Cheng (3 shared papers)Yau Yi Lau (3 shared papers)Tongtong Liu (2 shared papers)Wu‐Chun Cao (13 shared papers)David R. Nelson (1 shared paper)Edward T. Morgan (4 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (3 papers)Annals of Oncology (3 papers)British Journal of Clinical Pharmacology (3 papers)Drug Metabolism and Disposition (3 papers)New England Journal of Medicine (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Xiaoming Cui
62 papers receiving 4.3k citations
Xiaoming Cui's Hit Papers
Peers
Comparison fields: 5 of 131
- Parasitology 501
- Infectious Diseases 1.3k
- Pulmonary and Respiratory Medicine 983
- Pharmacology 303
- General Dentistry 8
Countries citing papers authored by Xiaoming Cui
This map shows the geographic impact of Xiaoming Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Cui more than expected).
Fields of papers citing papers by Xiaoming Cui
This network shows the impact of papers produced by Xiaoming Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Cui. The network helps show where Xiaoming Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoming Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins Hit paper breakdown → | 2020 | 1370 |
| 2 | Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer Hit paper breakdown → | 2020 | 743 |
| 3 | Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials Hit paper breakdown → | 2013 | 371 |
| 4 | 2006 | 237 | |
| 5 | Large-Scale Comparative Analyses of Tick Genomes Elucidate Their Genetic Diversity and Vector Capacities Hit paper breakdown → | 2020 | 222 |
| 6 | 2019 | 136 | |
| 7 | Distribution of Haemaphysalis longicornis and associated pathogens: analysis of pooled data from a China field survey and global published data Hit paper breakdown → | 2020 | 130 |
| 8 | 2022 | 114 | |
| 9 | 2002 | 113 | |
| 10 | 2020 | 84 | |
| 11 | Metavirome of 31 tick species provides a compendium of 1,801 RNA virus genomes Hit paper breakdown → | 2023 | 76 |
| 12 | 2015 | 68 | |
| 13 | 2004 | 63 | |
| 14 | 2017 | 58 | |
| 15 | 2000 | 54 | |
| 16 | 2007 | 50 | |
| 17 | 2021 | 48 | |
| 18 | Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor alpha-deficient mice upon lipopolysaccharide and clofibrate challenges. | 2001 | 44 |
| 19 | 2016 | 37 | |
| 20 | 2002 | 30 |
About Xiaoming Cui
Xiaoming Cui is a scholar working on Pharmacology, Parasitology, Infectious Diseases, Biochemistry and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 4.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (19 papers), Vector-borne infectious diseases (11 papers), Lung Cancer Treatments and Mutations (9 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Viral Infections and Vectors (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Parasitology (501 citations), Infectious Diseases (1.3k citations), Pulmonary and Respiratory Medicine (983 citations), Pharmacology (303 citations) and General Dentistry (8 citations). Xiaoming Cui has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Ronald E. White, Henry W. Strobel, K.-C. Cheng, Yau Yi Lau, Tongtong Liu, Wu‐Chun Cao, David R. Nelson, Edward T. Morgan, Lin Zhao and Yuhao Zhou. Their work appears in journals such as Signal Transduction and Targeted Therapy, Annals of Oncology, British Journal of Clinical Pharmacology, Drug Metabolism and Disposition and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.